A more eco-friendly range of diapers from Procter & Gamble has sparked an extraordinary online firestorm that is raising questions about how socially sensitive companies attempting to introduce sustainable technology to commercial products can evade popular backlash on the internet.

Brad Wilcox and Kathryn Sharpe of the University of Virginia have taken a fascinating fresh look at sectors of the economy most influenced by marriage and fertility.

Wilson H. Taylor, chairman of the Board of Trustees of the American Enterprise Institute, has announced that John E. Pepper was elected to the board on December 5 at its annual meeting.

Online communal wisdom should be harnessed for drug development.

Guidelines are what Peter Sims seeks to provide in "Little Bets," an enthusiastic, example-rich argument for innovating in a particular way—by deliberately experimenting and taking small exploratory steps in novel directions. Some little bets will not pay off, of course, in which case little is lost; but others may pay off in big ways.

U.S. Treasury bonds are declining in value, as investors recognize the long-term debt implications of more deficit spending to pay for the just-passed health care reform.

For the shift away from everyday drugs toward longshot, big-payoff remedies, you can thank regulators, insurers' reimbursement schemes, and the madness of tort litigation.

Economics and regulatory policy are driving pharmaceutical manufacturers away from the market for treating ordinary medical conditions toward drugs for major health problems.